Navigation Links
Study shows rise in antibiotic resistant pediatric head and neck infections
Date:1/19/2009

Highlights

  • Prevalence of antibiotic-resistant head and neck infections is increasing.
  • There is growing concern in the medical community about an epidemic of community acquired antibiotic resistant infections.
  • Clinicians must be judicious in prescribing antibiotics.

ATLANTA A report by researchers in the Jan. 19, 2009 Archives of Otolaryngology-Head and Neck Surgery shows that there was nationwide increase in the prevalence of pediatric methicillin-resistant Staphylococcus aureus (MRSA) head and neck infections from January 2001 to December 2006.

The increase in antibiotic-resistant infections has become a big concern for researchers and clinicians over the years. MRSA was once a condition that was only found in hospital settings; however, over the last decade MRSA outbreaks have increasingly been found in patients without risk factors.

In an attempt to identify trends in the susceptibility of antibiotic-resistant infections, researchers from Emory University School of Medicine and Children's Healthcare of Atlanta studied data on pediatric patients from nationwide hospitals.

"The growing concern about the recent worldwide MRSA epidemic has fueled the curiosity of the scientific community to gain insight into the clinical and epidemiologic manifestations of this microbe," says Steven E. Sobol, MD, MSc, primary investigator of the study and director of Pediatric Otolaryngology in the Department of Otolaryngology - Head and Neck Surgery at Emory.

"Previous studies have established that skin and soft tissue infections in some communities are due to MRSA," he says. "However, it has been observed in several institutions that there is a significant rise in pediatric head and neck infections as well."

The researchers reviewed a total of 21,009 pediatric head and neck S. aureus infections from 300 hospitals nationwide that occurred between Jan. 1, 2001 and Dec. 31, 2006. Patients ranged in ages from birth to 18.

In 2001, approximately 12 percent of all isolated S. aureus in the study was methicillin resistant. During the following five years, the number steadily rose to more than 28 percent. Overall during those six years there was a 16.3 percent increase in the percentage of resistance for all pediatric head and neck S. aureus infections.

"There is a nationwide increase in the prevalence of MRSA in children with head and neck infections that is alarming," says Sobol. "Clinicians must use antibiotic agents judiciously in order to reduce further antimicrobial drug resistance."

Sobol suggests that there be careful testing of suspected head and neck infections, leading to more appropriate antimicrobial drug selection. He also recommends further studies to gain additional insight into this organism.

Additional study investigators include Iman Naseri, MD, formerly of Emory's Department of OtolaryngologyHead and Neck Surgery and Robert C. Jerris, PhD, Children's Healthcare of Atlanta.

This study was supported by a grant from Alcon Laboratories Inc.

Reference: Nationwide Trends in Pediatric Staphylococcus aureus Head and Neck Infections, Archives of Otolaryngology Head and Neck Surgery/Vol 135 (No. 1): 14-16


'/>"/>

Contact: Kathi Baker
kobaker@emory.edu
404-727-9371
Emory University
Source:Eurekalert

Related medicine news :

1. Study: Growth in research comes at a steep price
2. National Childrens Study Begins Recruiting
3. A Study In This Months Journal Of Nervous And Mental Disease Reveals Hope For Recovery From Suicidal Thinking And Treatment Resistant Mental Illness
4. Tufts receives NIH grant to study obesity prevention in new immigrants
5. New Research From EBRI: Study Examines Issues in Capping Tax Exclusion of Health Coverage
6. 2009 Most Wired Survey and Benchmarking Study Opens Today
7. Seattle Reproductive Medicine Study Investigates Newly Formulated Medications for Luteal Support in IVF
8. Newer Antipsychotics Pose Cardiac Risk: Study
9. Study uses bone marrow stem cells to regenerate skin
10. Study shows surgery provides good long-term outcomes for patients with gastrointestinal cancers
11. TPHAC Reaction to Economic Impact Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 25, 2017 , ... ProRehab Physical Therapy (PRPT) ... physical therapy provider for Derby City CrossFit, effective immediately. , In addition to ... and effectively as possible, ProRehab’s sports physical therapists will work with athletes to ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report ... score performance for the 2015-16 school year across Wisconsin’s public schools, charter schools, ... highlights important patterns in student test score performance, the report’s limited analyses fail ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are ... help with process innovation in drug formulation and manufacturing. CoreRx offers its ... analytical equipment in support of their development and manufacturing goals. , The ...
(Date:4/25/2017)... , ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing ... acute or chronic problems, I focus on preventative care with all my patients to alleviate ... any questions, always feel free to contact my office and my trained staff will assist ...
(Date:4/25/2017)... ... 2017 , ... Vetoquinol USA® , a world-class developer ... of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. ... level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced ... Market Prospects: Addressing Production Complexities Through Risk Management and ... ... Pipeline and Market Prospects: Overcoming Production Complexities Through Risk ... of the current trends in the global biosimilars market, ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ... their offering. ... for drug delivery technologies will rise from USD 20 Billion in ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
Breaking Medicine Technology: